From 'perfect mix' to 'potion magique' - regulatory T cells and anti-inflammatory cytokines as adjuvant targets

被引：8

作者：

Bayry, Jagadeesh ^{[1
,2
,3
]}

Flower, Darren R. ^{[4
]}

Tough, David F. ^{[5
]}

Kaveri, Srini V. ^{[1
,2
,3
]}

机构：

[1] Univ Paris 06, Ctr Rech Cordeliers, UMRS 872, F-75006 Paris, France

[2] Univ Paris 05, UMRS 872, F-75006 Paris, France

[3] INSERM, U872, F-75006 Paris, France

[4] Univ Oxford, Jenner Inst, Compton RG20 7NN, Berks, England

[5] GlaxoSmithKline Inc, Target Discovery, RI CEDD, Stevenage SG1 2NY, Herts, England

来源：

NATURE REVIEWS MICROBIOLOGY | 2008年 / 6卷 / 01期

关键词：

D O I：

10.1038/nrmicro1681-c1

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：88 / 88

页数：4

共 17 条

[1] Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells [J].

Bayry, Jagadeesh ;

Triebel, Frederic ;

Kaveri, Srini V. ;

Tough, David F. .

JOURNAL OF IMMUNOLOGY, 2007, 178 (07) :4184-4193

[2] Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].

Caramalho, I ;

Lopes-Carvalho, T ;

Ostler, D ;

Zelenay, S ;

Haury, M ;

Demengeot, J .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411

[3] Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells [J].

Crellin, NK ;

Garcia, RV ;

Hadisfar, O ;

Allan, SE ;

Steiner, TS ;

Levings, MK .

JOURNAL OF IMMUNOLOGY, 2005, 175 (12) :8051-8059

[4] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].

Curiel, TJ ;

Coukos, G ;

Zou, LH ;

Alvarez, X ;

Cheng, P ;

Mottram, P ;

Evdemon-Hogan, M ;

Conejo-Garcia, JR ;

Zhang, L ;

Burow, M ;

Zhu, Y ;

Wei, S ;

Kryczek, I ;

Daniel, B ;

Gordon, A ;

Myers, L ;

Lackner, A ;

Disis, ML ;

Knutson, KL ;

Chen, LP ;

Zou, WP .

NATURE MEDICINE, 2004, 10 (09) :942-949

[5] Fms-like tyrosine kinase 3-based immunoprophylaxis against infection is improved by adjuvant treatment with anti-interleukin-10 antibody [J].

Das, L ;

DeVecchio, J ;

Heinzel, FP .

JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (04) :693-702

[6]

Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681

[7] Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation [J].

Houot, Roch ;

Perrot, Ivan ;

Garcia, Eric ;

Durand, Isabelle ;

Lebecque, Serge .

JOURNAL OF IMMUNOLOGY, 2006, 176 (09) :5293-5298

[8] Multi-faceted strategies to combat disease by interference with the chemokine system [J].

Johnson, Z ;

Schwarz, M ;

Power, CA ;

Wells, TNC ;

Proudfoot, AEI .

TRENDS IN IMMUNOLOGY, 2005, 26 (05) :268-274

[9] Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death [J].

Lewkowicz, Przemyslaw ;

Lewkowicz, Natalia ;

Sasiak, Andrzej ;

Tchorzewski, Henryk .

JOURNAL OF IMMUNOLOGY, 2006, 177 (10) :7155-7163

[10] Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF - Secreting cancer immunotherapy [J].

Li, Betty ;

Lalani, Alshad S. ;

Harding, Thomas C. ;

Luan, Bo ;

Koprivnikar, Kathryn ;

Tu, Guang Huan ;

Prell, Rodney ;

VanRoey, Melinda J. ;

Simmons, Andrew D. ;

Jooss, Karin .

CLINICAL CANCER RESEARCH, 2006, 12 (22) :6808-6816

← 1 2 →